| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2394753A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2365118A1 Inhibitor against human chymase activity |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118659A1 Expression systems for functional nucleic acid expression |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1118331A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/25/2001 | EP1117817A2 Therapeutically active proteins in plants |
| 07/25/2001 | EP1117801A2 Polyketide synthase enzymes and recombinant dna constructs therefor |
| 07/25/2001 | EP1117793A2 Secretory protein - zsig48 |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117782A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/25/2001 | EP1117781A2 Human membrane channel proteins |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117769A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 07/25/2001 | EP1117767A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 07/25/2001 | EP1117687A2 Compositions and methods for wt1 specific immunotherapy |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 07/25/2001 | EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 07/25/2001 | EP1117653A1 Chemical compounds |
| 07/25/2001 | EP1117651A1 New bis-benzimidazoles |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117646A1 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins |
| 07/25/2001 | EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/25/2001 | EP1117628A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 07/25/2001 | EP1117435A1 Mutant cholera holotoxin as an adjuvant |
| 07/25/2001 | EP1117434A2 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 07/25/2001 | EP1117430A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 07/25/2001 | EP1117429A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 07/25/2001 | EP1117421A2 Methods for therapeutic vaccination |
| 07/25/2001 | EP1117405A2 Composition and method for treating allergic diseases |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117390A1 Mucosal originated drug delivery systems and animal applications |
| 07/25/2001 | EP0794955B1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 07/25/2001 | EP0772610B9 Dihydrobenzofuranes |
| 07/25/2001 | EP0684944B1 Coupling product obtained from hystamine and an amino acid |
| 07/25/2001 | CN1305498A Peptide composition as immunogen for treatment of allergy |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/25/2001 | CN1305491A Crystalline forms of 1S-[1a(pha(2S, 3R), 9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]-amino] actahydro-6H-piridazino [1,2-A][1,2] diazepin-1-carboxamide |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305467A Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305462A Novel 1,5 and 3-O-substituted 1H-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, and method for the production and use thereof as medica |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase |
| 07/25/2001 | CN1305385A Method and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 07/25/2001 | CN1305371A Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1068879C Dihydrobenzofuranes |
| 07/25/2001 | CN1068792C Lycium chinese glycopeptide and its production process |
| 07/24/2001 | US6265588 Use as pharmaceuticals; as an antigen for production of antibodies and in diagnosis and purification |
| 07/24/2001 | US6265566 Nucleotide sequences coding plant protein; for diagnosing, treating and preventing allergic responses |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265551 Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof |
| 07/24/2001 | US6265450 Administering astexanthin |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265423 Skin disorders; anticancer agents |
| 07/24/2001 | US6265414 Treating sleep disorders using desloratadine |
| 07/24/2001 | US6265411 Oxindole derivatives |
| 07/24/2001 | US6265403 Angiogenesis inhibitors |
| 07/24/2001 | US6265215 Isolated peptides which complex with HLA-Cw16 and uses thereof |
| 07/24/2001 | US6265195 Nucleic acid of defined nucleotide sequence which codes for a deoxyribonuclease; for production of enough enzyme for clinical use; diagnosis; treatment of cystic fibrosis, lupus, chronic bronchitis, pneumonia, emphysema, and asthma |
| 07/24/2001 | US6265189 Expressing polypeptide in cell culture; insert gene into viral expression vector, transform cells, recover preferential polypeptide |
| 07/24/2001 | US6265183 Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins |
| 07/24/2001 | US6264958 Polynucleotide |
| 07/24/2001 | US6264955 Ferrichrome transport ATP-binding protein |
| 07/24/2001 | US6264950 Complex of protein and immunoglobulin |
| 07/24/2001 | US6264949 Administering label molecule |
| 07/24/2001 | US6264948 Methods and compositions for inhibiting tumor cell growth |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264917 Targeted ultrasound contrast agents |
| 07/24/2001 | US6264623 Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune disease |
| 07/24/2001 | CA2218503C Arylsulfonyl hydroxamic acid derivatives |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2019369C Sulfur-containing fused pyrimidine derivatives, their production and use |
| 07/19/2001 | WO2001051644A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN Cν3 AND Cν4 DOMAINS |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051608A2 Hybrid cells obtainable from antigen presenting cells |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051510A2 G-csf conjugates |
| 07/19/2001 | WO2001051507A1 Novel peptide and screening method by using the same |
| 07/19/2001 | WO2001051499A1 METHODS FOR SYNTHESIS OF α-D-GAL (1→3) GAL-CONTAINING OLIGOSACCHARIDES |
| 07/19/2001 | WO2001051493A1 Benzosulfones with calcium antagonist activity |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | WO2001051464A1 Novel vitamin d analogues |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051084A1 Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1 |